HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Selenium in the treatment of head and neck lymphedema.

AbstractOBJECTIVE: To investigate the impact of selenium in the treatment of lymphedema of the head and neck region after radiotherapy alone or in combination with surgery. SUBJECTS AND MATERIALS: Between June 1996 and June 2001 a total of 36 cancer patients (29 male, 7 female; median age 61 years) were treated with selenium for persistent, extensive or progressive lymphedema of the head and neck region. Twenty had interstitial endolaryngeal edema associated with stridor and dyspnea. All patients received 350 microg/m(2) body surface sodium selenite medication p.o. daily (total dose 50 microg per day) for a period of 4-6 weeks after radiotherapy. The optimal effect of the selenium treatment was assessed after 4 weeks of therapy using the Miller score system. A visual analogue scale on a scale of 0-10 was used to assess the patient's quality of life prior to and after selenium. RESULTS: 75% of the patients had an improvement of the Miller score of one stage or more. The self-assessment of quality of life using the visual analogue scale improved significantly after selenium treatment with a reduction of 4.4 points (p < 0.05). Of the 20 patients with endolaryngeal edema tracheostomy was not necessary in 13 patients (65%), but 5 and 2 received a temporary or permanent tracheostomy, respectively. No episode of erysipelas was observed in all study patients. CONCLUSION: Our results suggest a short positive effect of sodium selenite on secondary head and neck lymphedema caused by radiotherapy alone or in combination with surgery.
AuthorsF Bruns, J Büntzel, R Mücke, K Schönekaes, K Kisters, O Micke (Affiliation: Department of Radiotherapy, Medical School Hannover, Hannover, Germany.)
JournalMedical principles and practice : international journal of the Kuwait University, Health Science Centre (Med Princ Pract) 2004 Jul-Aug Vol. 13 Issue 4 Pg. 185-90 ISSN: 1011-7571 [Print] Switzerland
PMID15181321 (Publication Type: Clinical Trial, Journal Article)
CopyrightCopyright 2004 S. Karger AG, Basel
Chemical References
  • Sodium Selenite
Topics
  • Aged
  • Chemotherapy, Adjuvant
  • Female
  • Head and Neck Neoplasms (drug therapy, psychology, radiotherapy)
  • Humans
  • Lymphedema (drug therapy, psychology, radiotherapy)
  • Male
  • Middle Aged
  • Quality of Life
  • Sodium Selenite (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD